Log in to save to my catalogue

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neu...

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neu...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751210294

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Neurocognitive function, neurological symptoms, functional independence, and health-related quality of life are major concerns for patients with brain metastases. The inclusion of these endpoints in trials of brain metastases and the methods by which these measures are assessed vary substantially. If functional independence or health-relate...

Alternative Titles

Full title

Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1751210294

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751210294

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(13)70308-5

How to access this item